HeartSine Technologies LLC Strategic SWOT Analysis Review [Report Updated: 21022018] Prices from USD $125

19:55 EST 9 Mar 2018 | BioPortfolio Reports

HeartSine Technologies LLC Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.


This uptotheminute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.


Scope


Business description A detailed description of the company's operations and business divisions.

Corporate strategy GlobalData's summarization of the company's business strategy.

SWOT analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.

Key manufacturing facilities A list of key manufacturing facilities of the company.


Highlights


HeartSine Technologies LLC HeartSine, a subsidiary of PhysioControl, Inc., is a medical device company that develops automated external defibrillators AED for the treatment of sudden cardiac arrest. The core technologies of the company include advanced microprocessorbased energy switching and delivery system, selfcompensating output pulse envelope SCOPE biphasic technology, cardiac arrhythmia detection and diagnostic algorithms, impedance cardiogram based CPR rate advisor system and defibrillator electrode technologies. Its product portfolio includes Samaritan public access defibrillator PAD family of AEDs. HeartSine offers its products to various sectors including government, education, health and sports, hospitality, military, corporate offices, retail and transportation. The company offers its products through a network of distributors across North America, Europe, the Middle East, Asia and Africa regions. HeartSine is headquartered in Newton, Pennsylvania, the US.


Reasons to Buy


Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.


Note: Some sections may be missing if data is unavailable for the company.

Original Article: HeartSine Technologies LLC Strategic SWOT Analysis Review [Report Updated: 21022018] Prices from USD $125

NEXT ARTICLE

More From BioPortfolio on "HeartSine Technologies LLC Strategic SWOT Analysis Review [Report Updated: 21022018] Prices from USD $125"